Axsome Therapeutics Presents New Data and Post Hoc Analyses of Auvelity in Patients with Major Depressive Disorder at the American College of Neuropsychopharmacology ACNP 2023 Annu
Monday, December 11, 2023 1 min read
Key Takeaway: Axsome Therapeutics Presents New Data and Post Hoc Analyses of Auvelity in Patients with Major Depressive Disorder at the American College of Neuropsychopharmacology ACNP 2023 Annu
Full Press Release Details
Axsome Therapeutics Presents New Data and Post Hoc Analyses of Auvelity in Patients with Major Depressive Disorder at the American College of Neuropsychopharmacology ACNP 2023 Annu.